Factual end-of-day data for IPCALAB: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 4,55,426 shares was close to the 20-day average.
IPCALAB touched a fresh 52-week high in this session.
IPCALAB's delivery share of 43.7% was below its 20-day average of 46.8%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 1,045 shares on the buy side vs 668 on the sell side.
Largest single sell-side trade: 668 shares at ₹1,982.00.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 68.1 |
| 50-day EMA | ₹1,770.85 — close is above |
| 200-day EMA | ₹1,602.43 — close is above |
| SuperTrend (10, 3) | ₹1,724.36 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
IPCALAB is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹37,256 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 43.7% of IPCALAB's traded volume was marked for delivery (1,99,017 shares delivered). The 20-day average delivery is 46.8%.
IPCALAB closed at ₹1,952.40 on 26 Aug 2026 (+1.24% vs the previous close).
52-week high ₹1,992.00, 52-week low ₹1,251.60. The latest close is -1.99% from the 52-week high.